Thrasio, which is a consumer goods company working on omnichannel commerce, has made three new acquisitions, buying mattress protector company SafeRest, camping equipment company Wise Owl Outfitters and home bedding company Danjor Linens, according to a press release on Wednesday (Sept. 8).
Thrasio has been acquiring new and increasingly larger businesses. The company has doubled its average deal size and increased the pace of acquisitions. The new brands are expected to add over $90 million in sales within their first year, per the release.
“We’re building a consumer goods company that is rooted in customer feedback and established quality,” said Carlos Cashman, co-founder and co-CEO of Thrasio. “We take beloved products, invest the resources to solidify their category leadership on Amazon, and then we increase their sales footprint through international expansion and other channels. When a brand comes into our portfolio, it gains immediate value from our proven flywheel to grow stronger and reach even more happy customers.”
The deals come as Amazon-style aggregators become more commonplace. Entrepreneurs have come to a crossroads of sorts, as operating an Amazon FBA business has become difficult, and successful products become magnets for rivalries. That makes the prospect of an acquisition appealing. Sellers should ensure that acquisitions would provide well for their companies and make sure they’re well positioned for the future, according to the release.
Thrasio clarified that it selects companies for acquisition that have “excellent ratings across many reviews.”
Early in the year, Thrasio raised $750 million, with a trend toward money going to companies like it that frequently buy up Amazon third-party sellers. The deals have closely followed the Fulfillment by Amazon program, where Amazon stores a company’s products in an Amazon warehouse and then handles packing, shipping and customer service, the release stated.
Read more: Thrasio Pulls In $750 Million To Continue Acquisitions Of Amazon Sellers
The round in February was backed by mostly existing investors like Oaktree and Advent.
Thrasio had raised $500 million in debt financing in January from J.P. Morgan Chase and others.